Actively Recruiting
Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West
Led by University Hospital, Brest · Updated on 2025-02-06
100
Participants Needed
6
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Due to increasing of life expectancy, patients with von Willebrand disease are exposed to age-related pathologies such as cancer or cardiovascular diseases. Management of thrombotic events is challenging given the inherent bleeding risk in von Willebrand disease. Few data are currently available in the literature. The aim of the study is to describe the frequency and nature of arterial and venous thromboembolic events and atrial fibrillation in patients with von Willebrand disease in the West of France. The investigators will perform a retrospective multicenter study conducted in the von Willebrand population of the French West. Von Willebrand adult patients followed in one of the French West medical centers participating in the study, who presented deep vein thrombosis, pulmonary embolism, ischemic stroke, transient ischemic attack, acute coronary syndrome, acute limb ischemia, atrial fibrillation, arteriopathy of the lower limbs, angina will be eligible.
CONDITIONS
Official Title
Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have Von Willebrand disease
- Are an adult
- Are followed up in a reference center in the West of France (Caen, Brest, Nantes, Rennes, Le Mans, Angers)
- Have consented to be included in the BERHLINGO database
- Have experienced a thrombotic or embolic event or cardiovascular disease such as deep vein thrombosis, pulmonary embolism, ischemic stroke, transient ischemic attack, acute coronary syndrome, acute limb ischemia, angina, obliterating arteriopathy of the lower limbs, or atrial fibrillation
- Have not expressed opposition to participate
You will not qualify if you...
- Have expressed opposition to participate
- Have acquired von Willebrand syndrome
- Are under legal protection
- Are a minor
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
CHU d'Angers
Angers, France, 49933
Not Yet Recruiting
2
CHU de Brest
Brest, France, 29609
Actively Recruiting
3
CHU de Caen
Caen, France, 14033
Not Yet Recruiting
4
CH le MANS
Le Mans, France, 72037
Not Yet Recruiting
5
CHU de Nantes
Nantes, France, 44093
Not Yet Recruiting
6
CHU de Rennes
Rennes, France, 35033
Not Yet Recruiting
Research Team
B
Brigitte PAN PETESCH
CONTACT
S
Sara ROBIN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here